Symbicort 80 mikrog / 2.25 mikrog / inhalaatio inhalaatiosumute, suspensio Suomi - suomi - Fimea (Suomen lääkevirasto)

symbicort 80 mikrog / 2.25 mikrog / inhalaatio inhalaatiosumute, suspensio

astrazeneca oy - budesonide, formoterol fumarate dihydrate - inhalaatiosumute, suspensio - 80 mikrog / 2.25 mikrog / inhalaatio - formoteroli ja budesonidi

Comirnaty Euroopan unioni - suomi - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.

MYSOLINE 250 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

mysoline 250 mg tabletti

astrazeneca oy - primidonum - tabletti - 250 mg - primidoni

CITANEST 10 mg/ml injektioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

citanest 10 mg/ml injektioneste, liuos

astrazeneca oy - prilocaini hydrochloridum - injektioneste, liuos - 10 mg/ml - prilokaiini

XYLOCAIN 5 % voide Suomi - suomi - Fimea (Suomen lääkevirasto)

xylocain 5 % voide

astrazeneca oy - lidocainum - voide - 5 % - lidokaiini

XYLOCAIN 5 mg/ml kurlausvesi Suomi - suomi - Fimea (Suomen lääkevirasto)

xylocain 5 mg/ml kurlausvesi

astrazeneca oy - lidocaini hydrochloridum - kurlausvesi - 5 mg/ml - lidokaiini

FULCIN 125 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

fulcin 125 mg tabletti

astrazeneca uk limited - griseofulvinum - tabletti - 125 mg - griseofulviini

AVLOSULFON 100 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

avlosulfon 100 mg tabletti

astrazeneca uk limited - dapsonum - tabletti - 100 mg - dapsoni

EKVACILLIN injektio/infuusiokuiva-aine, liuosta varten Suomi - suomi - Fimea (Suomen lääkevirasto)

ekvacillin injektio/infuusiokuiva-aine, liuosta varten

astrazeneca oy - cloxacillinum natricum - injektio/infuusiokuiva-aine, liuosta varten - kloksasilliini

INDERAL 1 mg/ml injektioneste Suomi - suomi - Fimea (Suomen lääkevirasto)

inderal 1 mg/ml injektioneste

astrazeneca uk limited - propranololi hydrochloridum - injektioneste - 1 mg/ml - propranololi